Purchase Order 75F40120P00290
Award Date 6/17/20
Potential Completion Date 6/16/22
Potential Value $136K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a non-severable definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to the University of Montana for a base period of three years from September 30, 2018, to September 29, 2021, with a total potential value of $18,280,011.02 and an ultimate completion date of July 14, 2025. The contract is a cost-no-fee arrangement and does not have a set-aside designation. The...
- The National Institute of Allergy and Infectious Diseases awarded a $9.566 million definitive contract to University Of Montana for development of UM-1098, a novel synthetic TH17-inducing adjuvant and delivery system, on September 30, 2023, under firm fixed-price pricing with no set-aside. Work is performed in Missoula, MT. The contract develops a vaccine adjuvant platform targeting Lyme disease and other pathogens, leveraging the FBB-1 procapsid expression system for recombinant capsid...
- The National Institute of Allergy and Infectious Diseases awarded a definitive contract to the University of Montana for vaccine adjuvant discovery and development on September 6, 2019, with a ceiling value of $18.5 million and an ultimate completion date of September 29, 2027. The contract is cost-plus-no-fee and supports the Vaccine Adjuvant Discovery Program (VADP) under Executive Order 14398. Work focuses on identifying novel adjuvant candidates to augment human vaccine efficacy, with...
- The Food and Drug Administration awarded a definitive firm fixed-price contract valued at $61,806.10 to the State of Montana Department of Health and Human Services for human food inspection services in Helena, Montana, with an ultimate completion date of September 29, 2026. This contract was awarded without set-aside designation on September 29, 2025, to support the FDA's food safety and regulatory compliance mission. The Montana Department of Health and Human Services, operating through its...
- The Food and Drug Administration awarded a $400,000 firm fixed-price contract to the Regents of the University of Michigan on September 26, 2022, to advance regulatory science methodologies in drug development. Specifically, the contract supports the FDA's Broad Agency Announcement seeking research and development proposals across multiple areas of interest, with this award focused on advancing the science of in vitro studies, animal models, pharmacokinetic studies, and real-world evidence...
- The U.S. Food and Drug Administration (FDA) awarded a $503,739 definitive cost-no-fee contract to the University of Tennessee to conduct research on the evaluation of small animal models for COVID-19 and their application in nonclinical safety and efficacy studies of investigational therapeutics. This contract is not associated with a set-aside program. As a major public research institution and land-grant university, the University of Tennessee has extensive expertise in medical research,...
- This $222,355.58 federal contract was awarded by the Food and Drug Administration (FDA) to the University of Maryland, College Park to combat the COVID-19 infodemic through evidence-based misinformation management strategies. The contract has a definitive contract structure without any set-aside designations. The University of Maryland, College Park, a state-controlled institution of higher learning, was selected as the prime contractor for this award. The University of Georgia Research...
- <p>The Food and Drug Administration awarded a definitive firm fixed-price contract to the State Of Montana Department Of Health And Human Services for Montana human food inspections on September 19, 2024, with a ceiling value of $55,655.58.</p> <p>Place of performance is Helena, MT. The contract provides human food inspection services in support of FDA regulatory missions. The ultimate completion date is September 29, 2025.</p>
- The Montana Department of Public Health and Human Services (DPHHS), a state government entity, was awarded a $7,875 firm fixed-price purchase order contract by the Food and Drug Administration (FDA) to provide partnership services. This contract has no set-aside designation and was awarded on July 16, 2007, with an ultimate completion date of October 31, 2007. DPHHS, through its Business and Financial Services Division, has a history of providing specialized public health services to support...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $313,326 Firm Fixed Price contract to the University of Wisconsin System, operating through its University of Wisconsin - Madison division. The contract was awarded under a Broad Agency Announcement (BAA) for the "Development of Modernized Acinetobacter Baumannii Susceptibility Guidance for Recommended Antimicrobial Agents Using Pharmacometric Approaches". This contract is not associated with...